Peptide news
Each explainer is dated, opens with the key numbers and links to the primary source. Pending decisions are written as pending.
By Julian Caraulani · prices checked
News · November 15, 2026
Retatrutide Phase 3: 28.3% Weight Loss at 80 Weeks (Nov 2026)
Lilly's retatrutide Phase 3 results in numbers: 28.3% weight loss at 80 weeks, the head-to-head with Ozempic, and why it is not approved or sold legally yet.
Updated November 20, 2026
News · October 30, 2026
Peptide Compounding: 6 Peptides Covered, 503A Rule Pending (Nov 2026)
HHS lets 503A pharmacies compound six peptides under ten conditions while FDA's 503A rule is pending. The dates, the status on 20 Nov 2026 and today's prices.
Updated November 20, 2026